These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 16508131)

  • 1. [Treatment of primary osteoporosis in men].
    Yamaguchi T; Sugimoto T
    Clin Calcium; 2006 Mar; 16(3):474-9. PubMed ID: 16508131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evidence and utility of etidronate for the treatment of osteoporosis].
    Takada J; Iba K; Yamashita T; Yoshizaki T
    Clin Calcium; 2008 Oct; 18(10):1427-33. PubMed ID: 18830039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevention of fractures with therapeutic agents for osteoporosis].
    Hosoi T
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():596-601. PubMed ID: 15035197
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evidence for efficacy of active vitamin D3 as an anti-osteoporotic drug].
    Inoue D
    Clin Calcium; 2008 Oct; 18(10):1469-75. PubMed ID: 18830044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New development in bisphosphonate treatment. Bisphosphonates for the treatment of glucocorticoid-induced osteoporosis].
    Soen S
    Clin Calcium; 2009 Jan; 19(1):44-53. PubMed ID: 19122264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [First choice drug for treatment of osteoporosis and the strategic points for choice of drugs].
    Soen S
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():325-8. PubMed ID: 18159713
    [No Abstract]   [Full Text] [Related]  

  • 7. [Bone diseases with Pain. Osteoporosis].
    Hayashi Y
    Clin Calcium; 2007 Apr; 17(4):606-12. PubMed ID: 17404492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New development in bisphosphonate treatment. Clinical significance of combinatorial therapies with bisphosphonates and parathyroid hormone for osteoporosis].
    Takeuchi Y
    Clin Calcium; 2009 Jan; 19(1):85-90. PubMed ID: 19122268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strontium ranelate: vertebral and non-vertebral fracture risk reduction.
    Seeman E
    Curr Opin Rheumatol; 2006 Jun; 18 Suppl 1():S17-20. PubMed ID: 16735841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of pharmaceutical intervention in the treatment of osteoporosis and prevention of fracture].
    Nakamura T
    Nihon Rinsho; 2009 May; 67(5):903-8. PubMed ID: 19432107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Calcitonin].
    Nakano T
    Clin Calcium; 2008 Oct; 18(10):1460-8. PubMed ID: 18830043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bisphosphontes].
    Ichimura S
    Clin Calcium; 2005 Apr; 15(4):583-90. PubMed ID: 15802769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of monotherapy and combined therapy with calcitonin and minodronic acid hydrate, a bisphosphonate, for early treatment in patients with new vertebral fractures: An open-label, randomized, parallel-group study.
    Tanaka S; Yoshida A; Kono S; Ito M
    J Orthop Sci; 2017 May; 22(3):536-541. PubMed ID: 28108224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Zoledronic acid reduces risk of any new clinical fracture and risk of death after surgical repair of a low-trauma hip fracture].
    Leszczyński P
    Chir Narzadow Ruchu Ortop Pol; 2010; 75(3):168-71. PubMed ID: 21038635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Concurrent treatment of osteoporosis including vitamin K].
    Kobayashi S; Shiraki M; Takaoka K
    Clin Calcium; 2007 Nov; 17(11):1731-7. PubMed ID: 17982194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Regulation of bone mineralization by parathyroid hormone].
    Shimizu M; Tamura T
    Clin Calcium; 2004 Jun; 14(6):70-5. PubMed ID: 15577058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of bisphosphonate therapies for women with postmenopausal osteoporosis: implications of improved persistence with less frequently administered oral bisphosphonates.
    Earnshaw SR; Graham CN; Ettinger B; Amonkar MM; Lynch NO; Middelhoven H
    Curr Med Res Opin; 2007 Oct; 23(10):2517-29. PubMed ID: 17825128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Once-yearly administered intravenous zoledronic acid for postmenopausal osteoporosis.
    Woodis CB
    Ann Pharmacother; 2008 Jul; 42(7):1085-9. PubMed ID: 18505912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New bone density conservation agents for osteoporosis under research and development: PTH (1-34)].
    Endo I; Matsumoto T
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():443-6. PubMed ID: 18161146
    [No Abstract]   [Full Text] [Related]  

  • 20. [Anabolic treatment for osteoporosis: PTH treatment].
    Kaji H; Sugimoto T
    Clin Calcium; 2006 Sep; 16(9):1480-85. PubMed ID: 16951472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.